Healthcare Business News

J&J said to face demand to lift Risperdal settlement offer by $800 million

Posted: March 12, 2012 - 1:45 pm ET

Johnson & Johnson faces a U.S. government demand to raise its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing of the anti-psychotic Risperdal, according to three people familiar with the matter.


Advertisement | View Media Kit


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...



Switch to the new Modern Healthcare Daily News app

For the best experience of on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.